Acumen Pharmaceuticals, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2022 | $-8.3M | $-8.3M | $9.0K | $618.0K |
| Jun 2022 | $-6.5M | $-6.5M | $36.0K | $715.0K |
| Sep 2022 | $-9.2M | $-9.3M | $81.0K | $840.0K |
| Dec 2022 | $-11.2M | $-11.2M | $35.0K | $888.0K |
| Mar 2023 | $-10.2M | $-10.2M | $0 | $1.4M |
| Jun 2023 | $-11.7M | $-11.7M | $0 | $1.5M |
| Sep 2023 | $-12.9M | $-12.9M | $7.0K | $1.6M |
| Dec 2023 | $-8.3M | $-8.3M | $14.0K | $1.6M |
| Mar 2024 | $-17.9M | $-17.9M | $11.0K | $2.5M |
| Jun 2024 | $-16.5M | $-16.6M | $5.0K | $2.5M |
| Sep 2024 | $-24.6M | $-24.6M | $0 | $2.3M |
| Dec 2024 | $-27.2M | $-27.2M | $0 | $2.3M |
| Mar 2025 | $-34.1M | $-34.2M | $79.0K | $2.5M |
| Jun 2025 | $-31.8M | $-31.8M | $9.0K | $2.5M |
| Sep 2025 | $-30.5M | $-30.5M | $0 | $2.5M |
| Dec 2025 | $-19.1M | $-19.1M | $0 | $2.4M |
| Mar 2026 | $-24.1M | $-24.1M | $0 | $2.4M |
| Jun 2026 | $-18.1M | $-18.1M | $0 | $2.5M |